With the support of our senior scientific/biostatistical advisors and the vision created by Dr. Feagan, medical research and development is now led by Dr. Vipul Jairath. Our research investments have improved measurement in clinical trials through a truly global collaboration with clinical experts in inflammatory bowel disease (IBD) and other disciplines, and the rigorous development and validation of clinical outcomes measures in histopathology, endoscopy and imaging, as well as patient reported outcomes.
These outcome measures, developed with the goal of improving efficiency within clinical trials, are routinely incorporated into clinical drug development programs. We have contributed investment into large scale investigator-initiated trials designed to tackle important practice questions which have helped shaped care in the clinic for patients with IBD. We continue to invest in tomorrow’s leaders through the IBD Clinical Trials Fellowship program, often partnered with clinical fellowships at Western University, University of California San Diego and the Academic Medical Center, Amsterdam, the Netherlands.
These efforts have been possible through internal investment, peer reviewed charitable grants and industry collaborations. We are proud of the academic output in leading journals and eagerly look ahead to continuing our investment in and collaborations with the greater academic research community to refine and improve the treatment of gastrointestinal diseases.